Lille, France I 12-13-14 March 2024
An Evolving Landscape for Microbiome-based Medicinal Products
The microbiome represents true promise in the treatment and prevention of disease – it has already transformed our understanding of what it means to be ‘human’, that ‘health’ is in fact a continuum, and that both are the ultimate result of a complex interaction between host and one’s microbiomes.
Developing new therapeutic and diagnostic technologies based on microbiome science presents great challenges, beginning as early as the lab all the way to validating clinical trials and commercialization: microbiome-based biomarkers and diagnostic tools, animal-free models and their validation, data, AI and machine learning, and the latest microbiome regulatory science updates in a shifting landscape to give you and your partners a better vision for your development choices.
Are you a part of this exciting and dynamic community? Join us in Lille in March 2024 to find out the latest in microbiome-based medicinal product research and development and engage with other innovators and stakeholders in the field.
Conference Themes at Pharmabiotics 2024
Microbiome Modulation by Phages
Microbiome Regulatory Science Updates
Microbiome-based Biomarkers and Diagnostic Tools
Animal-Free Models & their Validation
Pharmaco-microbiomics
Data, AI & Machine Learning
President
Pharmabiotic Research Institute
Science Director
Yakult Europe
Michael Zimmermann
Robert Jan Brummer
Sin-Hyeog Im
Céline Druart
Professor, Department of Life Sciences POSTECH
CEO & Founder ImmunoBiome Inc
Executive Director
Pharmabiotic Research Institute
Advisory Committee
Bruno Pot
Sandrine Claus
Professor of Research
Institute of Agrochemistry and Food Technology (IATA-CSIC)
Françoise Le Vacon
Yolanda Sanz
Chief Scientific Officer
Biofortis
Pro-Vice-Chancellor, Professor
Örebro University
Group Leader
European Molecular Biology Laboratory
Julie Rodriguez
OMICS Project Manager
Pharmabiotic Research Institute
EU Microbiome Regulatory Science Center
The PRI is the European Microbiome Regulatory Science Expertise Center, created in 2010 to support the development and registration of therapeutic and diagnostic products emerging from microbiome science. We work to educate and contribute to the conditions of success for future medicinal innovations emerging from microbiome science, and our ultimate objective is to see these therapeutic innovations achieve EU marketing authorization, thereby giving European patients access to registered microbiome-based medicinal products or validated diagnostics.
“You are an expert in microbiome science.
Now it’s time to apply microbiome regulatory science.”
New Industries Require New Insight.
“Microbiome-based medicinal products – acting on host physiology through ecosystemic effects”
Event Sponsors 2024
